SYK

Stryker Corporation NYQ · SYK

$319.87 -11.33 (-3.42%)

Neutral · -0.04σ

+ Compare Open in Sniper

Mkt cap $122.6B

P/E 37.0

Day $318.08 – $329.26

52wk $281.00 – $389.33

Avg vol —

Beta —

Div yld 1.10%

Next earnings —

Quick read

Plain English

Stryker Corporation is a healthcare company listed in the US.

SYK last traded at $319.87, down 3.4% on the day; that's in the middle part of its 52-week range ($281.00–$389.33). Right now it's trading close to its recent average, with no strong stretch in either direction.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and day to day, watch whether it holds above or slips below its recent average.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

Today's read

Grading desk →

below KC1 upper, -0.06 ATR from EMA21 — no notable pattern

Long —

score 12 · tech 12 / 80 · support 0 / 20

above KC1 lower, -0.06 ATR from EMA21 · no notable pattern

· Stochastic bull cross

How this grade was earned

total 12 pts

Cycle position 6

Momentum 3

Market fit 3

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

Short —

score 15 · tech 15 / 80 · support 0 / 20

below KC1 upper, -0.06 ATR from EMA21 · no notable pattern

· RSI rolling over (50)
· Aligned with weak downtrend

How this grade was earned

total 15 pts

Cycle position 6

Momentum 3

Market fit 6

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $141.38 (fair range $141–$227); today's price sits 131% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Intrinsic (DCF)

$141.38

Fair-value range

$141.38 – $227.46

Margin of safety

-131%

Verdict

Overvalued

Accounting quality Weak

✓ Positive retained earnings
✓ Gross margin 65% (pricing power)

⚠ Debt exceeds cash
⚠ Quick ratio 0.90 (fragile)

Price implies ~15% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

SYK is a $122.6 billion company, priced at 37× last year's earnings.

Mkt cap $122.6B

P/E ttm 37.0

Fwd P/E 19.1

Beta —

Day range $318.08 – $329.26

52w range $281.00 – $389.33

Avg vol —

RSI(2) 39.1

ROE —

Net mgn —

FCF mgn 17.4%

Debt/Eq 0.66

Div yld 1.10%

Sector Healthcare

Industry Medical Devices

Next earn —

52-week range · today's price

$281.00$389.33